Contemporary medical therapy for gastroesophageal reflux disease

Ronnie Fass, Lee J. Hixson, Michael L. Ciccolo, Paul R Gordon, Glenn Hunter, William - Adamas-Rappaport

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Gastroesophageal reflux disease is a chronic disorder that requires long-term therapy in most patients. The appropriate medical therapy should be individualized to the severity of symptoms, the degree of esophagitis and the presence of other acid-reflux complications. Lifestyle changes should form the basis of any therapeutic approach. In patients with mild to moderate disease, initial therapy with histamine H2-receptor antagonists in conventional dosages is suggested. Prokinetic agents are potentially useful in patients with impaired esophageal or gastric motor function, but their efficacy as single agents does not appear to surpass that of standard doses of H2 blockers. Sucralfate, a cytoprotective agent, is an additional therapeutic option. For patients with more severe disease, omeprezole and lansoprazole provide unequaled healing rates and accelerated symptom relief. In most patients, maintenance therapy is vital. Surgery is indicated in patients whose disease is refractory to medical therapy and in those who develop complications not amenable to medical therapy.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
JournalAmerican Family Physician
Volume55
Issue number1
StatePublished - 1997

Fingerprint

Gastroesophageal Reflux
Therapeutics
Sucralfate
Histamine H2 Antagonists
Lansoprazole
Esophagitis
Life Style
Stomach
Acids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Contemporary medical therapy for gastroesophageal reflux disease. / Fass, Ronnie; Hixson, Lee J.; Ciccolo, Michael L.; Gordon, Paul R; Hunter, Glenn; Adamas-Rappaport, William -.

In: American Family Physician, Vol. 55, No. 1, 1997, p. 205-212.

Research output: Contribution to journalArticle

Fass, R, Hixson, LJ, Ciccolo, ML, Gordon, PR, Hunter, G & Adamas-Rappaport, W 1997, 'Contemporary medical therapy for gastroesophageal reflux disease', American Family Physician, vol. 55, no. 1, pp. 205-212.
Fass, Ronnie ; Hixson, Lee J. ; Ciccolo, Michael L. ; Gordon, Paul R ; Hunter, Glenn ; Adamas-Rappaport, William -. / Contemporary medical therapy for gastroesophageal reflux disease. In: American Family Physician. 1997 ; Vol. 55, No. 1. pp. 205-212.
@article{951f4a0bb2ea40fb9289f9e7b825741e,
title = "Contemporary medical therapy for gastroesophageal reflux disease",
abstract = "Gastroesophageal reflux disease is a chronic disorder that requires long-term therapy in most patients. The appropriate medical therapy should be individualized to the severity of symptoms, the degree of esophagitis and the presence of other acid-reflux complications. Lifestyle changes should form the basis of any therapeutic approach. In patients with mild to moderate disease, initial therapy with histamine H2-receptor antagonists in conventional dosages is suggested. Prokinetic agents are potentially useful in patients with impaired esophageal or gastric motor function, but their efficacy as single agents does not appear to surpass that of standard doses of H2 blockers. Sucralfate, a cytoprotective agent, is an additional therapeutic option. For patients with more severe disease, omeprezole and lansoprazole provide unequaled healing rates and accelerated symptom relief. In most patients, maintenance therapy is vital. Surgery is indicated in patients whose disease is refractory to medical therapy and in those who develop complications not amenable to medical therapy.",
author = "Ronnie Fass and Hixson, {Lee J.} and Ciccolo, {Michael L.} and Gordon, {Paul R} and Glenn Hunter and Adamas-Rappaport, {William -}",
year = "1997",
language = "English (US)",
volume = "55",
pages = "205--212",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "1",

}

TY - JOUR

T1 - Contemporary medical therapy for gastroesophageal reflux disease

AU - Fass, Ronnie

AU - Hixson, Lee J.

AU - Ciccolo, Michael L.

AU - Gordon, Paul R

AU - Hunter, Glenn

AU - Adamas-Rappaport, William -

PY - 1997

Y1 - 1997

N2 - Gastroesophageal reflux disease is a chronic disorder that requires long-term therapy in most patients. The appropriate medical therapy should be individualized to the severity of symptoms, the degree of esophagitis and the presence of other acid-reflux complications. Lifestyle changes should form the basis of any therapeutic approach. In patients with mild to moderate disease, initial therapy with histamine H2-receptor antagonists in conventional dosages is suggested. Prokinetic agents are potentially useful in patients with impaired esophageal or gastric motor function, but their efficacy as single agents does not appear to surpass that of standard doses of H2 blockers. Sucralfate, a cytoprotective agent, is an additional therapeutic option. For patients with more severe disease, omeprezole and lansoprazole provide unequaled healing rates and accelerated symptom relief. In most patients, maintenance therapy is vital. Surgery is indicated in patients whose disease is refractory to medical therapy and in those who develop complications not amenable to medical therapy.

AB - Gastroesophageal reflux disease is a chronic disorder that requires long-term therapy in most patients. The appropriate medical therapy should be individualized to the severity of symptoms, the degree of esophagitis and the presence of other acid-reflux complications. Lifestyle changes should form the basis of any therapeutic approach. In patients with mild to moderate disease, initial therapy with histamine H2-receptor antagonists in conventional dosages is suggested. Prokinetic agents are potentially useful in patients with impaired esophageal or gastric motor function, but their efficacy as single agents does not appear to surpass that of standard doses of H2 blockers. Sucralfate, a cytoprotective agent, is an additional therapeutic option. For patients with more severe disease, omeprezole and lansoprazole provide unequaled healing rates and accelerated symptom relief. In most patients, maintenance therapy is vital. Surgery is indicated in patients whose disease is refractory to medical therapy and in those who develop complications not amenable to medical therapy.

UR - http://www.scopus.com/inward/record.url?scp=0031030186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031030186&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 205

EP - 212

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 1

ER -